Newegg Commerce, Inc. (NEGG) Stock Price & Analysis
Newegg Commerce, Inc. (NEGG) fell 7.04% to USD 15.32 as of September 8, 2026 at 07:34 UTC, according to Nexqual real-time market data.
NEGG last closed at USD 16.48; the session ranged USD 15.19–16.45 on volume of 96,189 shares. Market capitalization is $321.32M, with a 52-week range of USD 12.5–96.29 (NCM). Source: Nexqual, September 8, 2026 at 07:34 UTC.
Key Statistics (as of September 8, 2026 at 07:34 UTC)
| Price | USD 15.32 |
|---|---|
| Change | ▼ 7.04% (down) |
| Previous Close | USD 16.48 |
| Open | USD 16.45 |
| Day Range | USD 15.19 – 16.45 |
| 52-Week Range | USD 12.5 – 96.29 |
| Volume | 96,189 shares |
| Market Cap | $321.32M |
| Exchange | NCM |
Technical Analysis (NEGG)
Nexqual's technical model rates NEGG "SELL" based on 2 bullish and 5 bearish signals across 128 daily candles, as of September 8, 2026 at 07:34 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 43.3 (neutral) |
| vs SMA50 | Below (USD 15.94) |
| MACD | -0.08 (negative) |
Analyst Ratings (NEGG)
Wall Street analysts rate NEGG "None", per Nexqual as of September 8, 2026 at 07:34 UTC.
| Consensus Rating | None |
|---|
Earnings (NEGG)
| Next Earnings Date | 2026-08-27 |
|---|
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2022-12-31 | USD -1.49 vs est -0.4 ▼ miss |
Source: Nexqual, September 8, 2026 at 07:34 UTC.
Financials & Fundamentals (NEGG)
| Total Revenue | $1.38B |
|---|---|
| Revenue Growth (YoY) | -8.10% |
| Gross Margin | +12.52% |
| Operating Margin | +0.44% |
| Profit Margin | +0.68% |
| ROE | +6.54% |
| Debt / Equity | 30.66 |
| Current Ratio | 1.55 |
| Total Cash | $82.24M |
| Total Debt | $52.47M |
| Free Cash Flow | $-9.22M |
Source: Nexqual, September 8, 2026 at 07:34 UTC.
Financial Health Score (NEGG)
Nexqual rates Newegg Commerce, Inc.'s overall financial health "Weak" across five dimensions, as of September 8, 2026 at 07:34 UTC.
| Growth | Critical — Revenue -19% YoY (annual), sharp decline |
|---|---|
| Profitability | Weak — Gross margin 13%, operating 0% |
| Balance Sheet | Solid — $82M cash vs $52M debt, net cash position |
| Cash Flow | Weak — FCF negative: -$9M, burning cash |
| Efficiency | Mixed — ROE 7%, ROA 1.1% |
Ownership (NEGG)
| Insider Ownership | +95.17% |
|---|---|
| Institutional Ownership | +0.48% |
| Shares Outstanding | 20.97M |
| Float | 1.37M |
| Short % of Float | +29.49% |
Source: Nexqual, September 8, 2026 at 07:34 UTC.
Leadership (NEGG)
Newegg Commerce, Inc. is led by Anthony K. Chow (age 59), CEO & Director, per Nexqual as of September 8, 2026 at 07:34 UTC.
| CEO & Director | Anthony K. Chow (age 59) |
|---|---|
| Founder & Director | Faching Chang (age 69) |
| Interim Chief Financial Officer | Christina S. Ching (age 57) |
Major Backers & Investors (NEGG)
Notable institutional backers of Newegg Commerce, Inc. include Penserra Capital Management LLC, Amplify ETF Trust-Amplify Online Retail ETF, according to Nexqual as of September 8, 2026 at 07:34 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Penserra Capital Management LLC | 0.11% |
| Amplify ETF Trust-Amplify Online Retail ETF | 0.11% |
Source: Nexqual, September 8, 2026 at 07:34 UTC.
From Newegg Commerce, Inc.'s Latest SEC 10-K Filing (filed 2013-03-18)
Key Strengths & Strategy (as disclosed to the SEC)
- Medical Devices (Including Related Supporting Products) Sleep Respiratory and Oxygen Therapy Products Research and Development of Our Proprietary Products Our success to date has in part resulted from our strong research and development capabilities, which allow us to regularly introduce new and more advanced products at competitive prices.
- This integrated approach allows us to identify potential difficulties in commercializing our proprietary product or product improvement.
- Most of our proprietary products require light assembly by us before distribution.
- Recent Developments Our Products Our proprietary and distributed products include two major categories: (i) medical devices (including supporting products) and (ii) sleep respiratory and oxygen therapy products (previously defined as respiratory and oxygen homecare products).
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| ATER | Aterian, Inc. | USD 0.63 | ▲ 22.99% |
| BBIG | Vinco Ventures, Inc. | USD 0 | ▲ 0% |
| XELA | Exela Technologies, Inc. | USD 0 | ▲ 0% |
| BKKT | Bakkt, Inc. | USD 8.33 | ▲ 12.11% |
| ALF | Centurion Acquisition Corp. | USD 10.89 | ▲ 0% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 07:34 UTC. This page is informational and not investment advice.